Essential thrombocythaemia in a teenage girl resulting in acquired von Willebrand syndrome with joint haemorrhage and menorrhagia

Nina Rolf; Meinolf Suttorp; Ulrich Budde; Gabriele Siegert; Ralf Knoefler

doi:10.1160/TH09-12-0871

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2010; 103(06): 1272-1274
DOI: 10.1160/TH09-12-0871

Letters to the Editor

Schattauer GmbH

Essential thrombocythaemia in a teenage girl resulting in acquired von Willebrand syndrome with joint haemorrhage and menorrhagia

Authors

Nina Rolf

¹Division of Oncology/Hematology/BMT, Child & Family Research Institute, BC Children’s Hospital, Vancouver, British Columbia, Canada

²Department of Paediatric Hematology, Oncology and Hemostaseology, Children’s Hospital, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
Meinolf Suttorp

²Department of Paediatric Hematology, Oncology and Hemostaseology, Children’s Hospital, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
Ulrich Budde

³Medilys Laboratory, Hamburg, Germany
Gabriele Siegert

⁴Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
Ralf Knoefler

²Department of Paediatric Hematology, Oncology and Hemostaseology, Children’s Hospital, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany

Abstract

Full Text

References

References
1 El-Moneim AA, Kratz CP, Böll S. et al. Essential versus reactive thrombocythaemia in children: retrospective analyses of 12 cases. Pediatr Blood Cancer 2007; 49: 52-55.
2 Hasle H. Incidence of essential thrombocythaemia in children. Br J Haematol 2000; 110: 751.
3 Putti MC, Giona F, Consario C. et al. Retrospective evaluation of 90 children with essential thrombocythaemia: the AIEOP Experience. Blood 2008; 112: 248.
4 Dror Y, Zipursky A, Blanchette VS. Essential thrombocythemia in children. J Pediatr Hematol Oncol 1999; 21: 356-363.
5 Randi ML, Putti MC, Fabris F. et al. Features of essential thrombocythaemia in childhood: a study of five children. Br J Haematol 2000; 108: 86-89.
6 Scherer S, Ferrari R, Rister M. Treatment of essential thrombocythaemia in childhood. Pediatr Hematol Oncol 2003; 20: 361-365.
7 Randi ML, Putti MC, Scapin M. et al. Pediatric patients with essential thrombocythaemia are mostly polyclonal and V617FJAK2 negative. Blood 2006; 108: 3600-3602.
8 Budde U, Schneppenheim R, Plendl H. et al. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost 1990; 63: 312-315.
9 Dame C, Sutor AH. Primary and secondary thrombocytosis in childhood. Br J Haematol 2005; 129: 165-177.
10 Barbui T, Barosi G, Grossi A. et al. Practice guidelines for the therapy of essential thrombocythaemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica 2004; 89: 215-232.
11 Budde U, Schneppenheim R. Von Willebrand factor and von Willebrand disease. Rev Clin Exp Hematol 2001; 05: 335-368.
12 Franchini M, Lippi G. Acquired von Willebrand syndrome: an update. Am J Hematol 2007; 82: 368-375.
13 Budde U, Scharf RE, Franke P. et al. Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma. Blood 1993; 82: 1749-1757.
14 Shim K, Anderson PJ, Tuley EA. et al. Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood 2008; 111: 651-657.
15 Budde U, Dent JA, Berkowitz SD. et al. Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome. Blood 1986; 68: 1213-1217.
16 Michiels JJ, Budde U, van der Planken M. et al. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best Pract Res Clin Haematol 2001; 14: 401-436.
17 Michiels JJ, Berneman Z, Schroyens W. et al. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and haemorrhagic manifestations in essential thrombocythaemia and polycythemia vera. Semin Thromb Hemost 2006; 32: 589-604.
18 Krebs M, Meyer B, Quehenberger P. et al. Massive postoperative intramuscular bleeding in acquired von Willebrand’s disease. Ann Hematol 2002; 81: 394-396.
19 Schneppenheim R. The evolving classification of von Willebrand syndrome. Blood Coagul Fibrinolysis 2005; 16 (Suppl. 01) S3-S10.
20 Federici AB, Rand JH, Bucciarelli P. et al. Acquired von Willebrand syndrome: Data from an International Registry. Thromb Haemost 2000; 84: 345-349.
21 Budde U, van Genderen PJ. Acquired von Wille-brand syndrome in patients with high platelet counts. Semin Thromb Hemost 1997; 23: 425-431.
22 Michiels JJ. Acquired von Willebrand syndrome due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythaemia. Clin Appl Thromb Hemost 1999; 05: 147-151.
23 Federici AB, Budde U, Rand JH. Acquired von Willebrand syndrome 2004: International Registry – diagnosis and management from online to bedside. Hämostaseologie 2004; 24: 50-55.